3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
56
Ovarian Neoplasms
35
Carcinoma, Hepatocellular
35
Neoplasms
25
Fallopian Tube Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Endometrial Neoplasms
13
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Colonic Neoplasms
9
Lung Neoplasms
8
Uterine Cervical Neoplasms
7
Liver Neoplasms
7
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Stomach Neoplasms
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Neoplasms
3
Interventions
Temozolomide
3
Specimen Handling
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
larotrectinib
1
balstilimab
1
Vaccines
1
Receptors, Interleukin-8B
1
Radiotherapy
1
Pharmacogenomic Variants
1
Pharmacogenomic Testing
1
PTC596
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Injections
1
Immune Checkpoint Inhibitors
1
Fluid Therapy
1
Everolimus
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
Diffusion Tensor Imaging
1
Cilengitide
1
CLR1404
1
CBLC137
1
Biopsy
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
Bevacizumab
×
90 days
×
Clear all
No trials found.